Brimonidine Tartrate Solution/ Drops
Loading...Brimonidine Tartrate Solution/ Drops Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The lOP lowering efficacy of brimonidine tartrate ophthalmic solution 0.2% diminishes over time in some patients. This loss of effect appears with a variable time of onset in each patient and should be closely monitored.
History
There is currently no drug history available for this drug.
Other Information
Brimonidine Tartrate Ophthalmic Solution 0.2% is a relatively selective alpha-2 adrenergic agonist for ophthalmic use. In solution, brimonidine tartrate ophthalmic solution 0.2% has a clear, greenish-yellow color. It has an osmolality of 280-330 mOsml/kg and a pH of 5.6-6.6 The structural formula is
C11H10BrN5 • C4H6O6
Mol. Wt. 442.24 (as the tartrate salt)
Chemical Name: 5-bromo-6-(2-imidazolidinylideneamino) quinoxaline L-tartrate.
CAS Number 59803-98-4
Each mL Contains:
ACTIVE: Brimonidine tartrate: 0.2% (2 mg/mL).
INACTIVES: Citric Acid, Polyvinyl Alcohol, Sodium Chloride, Sodium Citrate, Purified Water. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH.
PRESERVATIVE ADDED: Benzalkonium Chloride (0.05 mg).
Sources
Brimonidine Tartrate Solution/ Drops Manufacturers
-
Physicians Total Care, Inc.
![Brimonidine Tartrate Solution/ Drops [Physicians Total Care, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Brimonidine Tartrate Solution/ Drops | Physicians Total Care, Inc.
The recommended dose is one drop of brimonidine tartrate ophthalmic solution 0.2% in the affected eye(s) three times daily, approximately 8 hours apart.
Brimonidine tartrate ophthalmic solution 0.2% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
-
Pacific Pharma, Inc.
Brimonidine Tartrate Solution/ Drops | Pacific Pharma, Inc.
The recommended dose is one drop of Brimonidine tartrate ophthalmic solution in the affected eye(s) three times daily, approximately 8 hours apart.
Brimonidine tartrate ophthalmic solution may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
-
Bausch & Lomb Incorporated
Brimonidine Tartrate Solution/ Drops | Bausch & Lomb Incorporated
The recommended dose is one drop of brimonidine tartrate ophthalmic solution 0.2% in the affected eye(s) three times daily, approximately 8 hours apart.
Brimonidine tartrate ophthalmic solution 0.2% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
-
Remedyrepack Inc.
Brimonidine Tartrate Solution/ Drops | Remedyrepack Inc.
The recommended dose is one drop of brimonidine tartrate ophthalmic solution 0.2% in the affected eye(s) three times daily, approximately 8 hours apart.
Brimonidine tartrate ophthalmic solution 0.2% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
-
Remedyrepack Inc.
Brimonidine Tartrate Solution/ Drops | Remedyrepack Inc.
The recommended dose is one drop of brimonidine tartrate ophthalmic solution 0.2% in the affected eye(s) three times daily, approximately 8 hours apart.
Brimonidine tartrate ophthalmic solution 0.2% may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
![Brimonidine Tartrate Solution/ Drops [Pacific Pharma, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=d8a94e6e-2f61-4589-bb73-65c9c7884797&name=carton.jpg)
![Brimonidine Tartrate Solution/ Drops [Bausch & Lomb Incorporated]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=865f88b0-b13e-4607-a314-939f1b331e6f&name=9992cdcd-fb1e-428b-9be6-75460a4257bf-03.jpg)
![Brimonidine Tartrate Solution/ Drops [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=398d8461-a2e1-444a-8ee0-0f277af8be19&name=MM2.jpg)
![Brimonidine Tartrate Solution/ Drops [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=52e20c58-8ef8-4790-919e-5801a997e0d3&name=MM2.jpg)
Login To Your Free Account